180 Life Sciences Corp. financial data

Symbol
ATNF, ATNFW on Nasdaq
Location
3000 El Camino Real, Bldg 4, Ste 200, Palo Alto, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 837 % +1705%
Debt-to-equity 123 % -86.8%
Return On Equity -193 % +65.5%
Return On Assets -86.2 % -59.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 21.4M shares +982%
Common Stock, Shares, Outstanding 16.7M shares +1523%
Entity Public Float 1.55M USD -73.5%
Common Stock, Value, Issued 1.67K USD +1517%
Weighted Average Number of Shares Outstanding, Basic 12.4M shares +12563%
Weighted Average Number of Shares Outstanding, Diluted 12.4M shares +12563%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 4.11M USD
Research and Development Expense 1.34M USD -24.8%
General and Administrative Expense 229M USD +4305%
Operating Income (Loss) -226M USD -3681%
Nonoperating Income (Expense) 16.3M USD +414%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -218M USD -7613%
Income Tax Expense (Benefit) -2.35M USD
Net Income (Loss) Attributable to Parent -225M USD -7111%
Earnings Per Share, Basic -26 USD/shares -1208%
Earnings Per Share, Diluted -26 USD/shares -1208%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 53.3M USD
Marketable Securities, Current 8.83M USD
Assets, Current 562M USD +45759%
Intangible Assets, Net (Excluding Goodwill) 7.62M USD +387%
Goodwill 0 USD
Assets 1.01B USD +9540%
Accounts Payable, Current 1.2M USD -42.7%
Accrued Liabilities, Current 373K USD -20%
Liabilities, Current 55.8M USD +774%
Deferred Income Tax Liabilities, Net 342K USD +22.8%
Liabilities 564M USD +8275%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.56M USD +14.3%
Retained Earnings (Accumulated Deficit) -362M USD -180%
Stockholders' Equity Attributable to Parent 445M USD +11822%
Liabilities and Equity 1.01B USD +9540%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -854K USD +17.4%
Net Cash Provided by (Used in) Financing Activities -3.32M USD -1156%
Common Stock, Shares Authorized 5B shares +4900%
Common Stock, Shares, Issued 16.7M shares +1523%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -861K USD +33.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 559M USD +372161%
Interest Paid, Excluding Capitalized Interest, Operating Activities 12.1K USD +66.2%
Deferred Tax Assets, Valuation Allowance 19.5M USD +4.65%
Deferred Tax Assets, Gross 20.7M USD +7.46%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -233M USD -7047%
Deferred Income Tax Expense (Benefit) 2.3M USD
Deferred Tax Assets, Operating Loss Carryforwards 17.5M USD +6.44%
Preferred Stock, Shares Authorized 5M shares 0%
Additional Paid in Capital 826M USD +508%
Amortization of Intangible Assets 23.6K USD +8.29%
Share-based Payment Arrangement, Expense 34.4M USD +206848%
Interest Expense 49.7K USD +326%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%